Folding versus charge: Understanding selective target recognition by the thrombin aptamers

Current Pharmaceutical Design

Volumn 18, Issue 14, 2012, Pages 2027-2035

  Marson, Giuseppe ^a   Palumbo, Manlio ^a   Sissi, Claudia ^a  

^a Dept of Pharmaceutical and Pharmacological Sciences ^*  (Italy)

Author keywords

Aptamer; G quadruplex; Single stranded dna; Thrombin

Indexed keywords

APTAMER; DNA; FIBRINOGEN; GUANINE QUADRUPLEX; HEPARIN; OLIGONUCLEOTIDE; THROMBIN; THROMBIN APTAMER; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DNA PROTEIN COMPLEX; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; STATIC ELECTRICITY;

APTAMERS, NUCLEOTIDE; CIRCULAR DICHROISM; DNA; HUMANS; NUCLEIC ACID CONFORMATION; STATIC ELECTRICITY; THROMBIN;

EID: 84860179785     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799958323     Document Type: Article

References (39)

1. Barbas AS, Mi J, Clary BM, White RR. Aptamer applications for targeted cancer therapy. Future Oncol 2010; 6: 1117-1126.
2. Rayburn ER, Zhang R. Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov Today 2008; 13: 513-521.
3. Bunka DH, Platonova O, Stockley PG. Development of aptamer therapeutics. Curr Opin Pharmacol 2010; 10: 557-562.
4. Bouchard PR, Hutabarat RM, Thompson KM. Discovery and development of therapeutic aptamers. Annu Rev Pharmacol Toxicol 2010; 50: 237-257.
5. Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000; 287: 820-825.
6. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-822.
7. Stoltenburg R, Reinemann C, Strehlitz B. SELEX-a (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng 2007; 24: 381-403.
8. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-510.
9. Mann KG. Thrombin: can't live without it, probably die from it. Chest 2003; 124: 1S-3S.
10. Di Cera E. Thrombin. Mol Aspects Med 2008; 29, 203-254.
11. Stubbs MT, Bode W. The clot thickens: clues provided by throm- bin structure. Trends Biochem Sci 1995; 20: 23-28.
12. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005, 106: 2605-2612.
13. Carter WJ, Cama E, Huntington JA. Crystal structure of thrombin bound to heparin. J Biol Chem 2005; 280, 2745-2749.
14. Fortenberry YM, Whinna HC, Gentry HR, Myles T, Leung LL, Church FC. Molecular mapping of the thrombin-heparin cofactor II complex. J Biol Chem 2004; 279: 43237-43244.
15. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992; 355: 564-566.
16. Trajkovski M, Sket P, Plavec J. Cation localization and movement within DNA thrombin binding aptamer in solution. Org Biomol Chem 2009; 7: 4677-4684.
17. Wang KY, Krawczyk SH, Bischofberger N, Swaminathan S, PH B. The tertiary structure of a DNA aptamer which binds to and inhibits thrombin determines activity. Biochemistry 1993; 112854-112892.
18. Macaya RF, Schultze P, Smith FW, Roe JA, Feigon J. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc Natl Acad Sci USA 1993; 90: 3745-3749.
19. Kuryavyi V, Majumdar A, Shallop A et al. A double chain reversal loop and two diagonal loops define the architecture of a unimolecu-lar DNA quadruplex containing a pair of stacked G(syn)-G(syn)-G(anti)-G(anti) tetrads flanked by a G-(T-T) triad and a T-T-T triple. J Mol Biol 2001; 310: 181-194.
20. Mao XA, Gmeiner WH. NMR study of the folding-unfolding mechanism for the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG). Biophys Chem 2005; 113: 155-160.
21. Nagatoishi S, Tanaka Y, Tsumoto K. Circular dichroism spectra demonstrate formation of the thrombin-binding DNA aptamer G-quadruplex under stabilizing-cation-deficient conditions. Biochem Biophys Res Commun 2007; 352: 812-817.
22. Padmanabhan K, Padmanabhan KP, Ferrara JD, Sadler JE, Tulin-sky A. The structure of alpha-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol Chem 1993; 268: 17651-17654.
23. Kelly JA, Feigon J, Yeates TO. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). J Mol Biol 1996; 256: 417-422.
24. Padmanabhan K, Tulinsky A. An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr D Biol Crystallogr 1996; 52: 272-282.
25. Pagano B, Martino L, Randazzo A, Giancola C. Stability and binding properties of a modified thrombin binding aptamer. Biophys J 2008; 94: 562-569.
26. Nagatoishi S, Isono N, Tsumoto K, Sugimoto N. Loop residues of thrombin-binding DNA aptamer impact G-quadruplex stability and thrombin binding. Biochimie 2011; 1231-1238.
27. Tasset DM, Kubik MF, Steiner W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol 1997; 272: 688-698.
28. + ions. Gen Physiol Biophys 2008; 27: 271-277.
29. Healy JM, Lewis SD, Kurz M, et al. Pharmacokinetics and biodis-tribution of novel aptamer compositions. Pharm Res 2004; 21: 2234-2246.
30. Becker RC, Rusconi C, Sullenger B. Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application. Thromb Haemost 2005; 93: 1014-1020.
31. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 2003; 270: 1628-1644.
32. Kuwahara M, Sugimoto N. Molecular evolution of functional nucleic acids with chemical modifications. Molecules 2010; 15: 5423-5444.
33. Zhou G, Huang X, Qu Y. The binding effect of aptamers on throm-bin. Biochem Engineering J 2010; 52: 117-122.
34. Lu M, Guo Q, Kallenbach NR. Thermodynamics of G-tetraplex formation by telomeric DNAs. Biochemistry 1993; 32: 598-601.
35. Kankia BI, Marky LA. Folding of the thrombin aptamer into a G-quadruplex with Sr(2+): stability, heat, and hydration. J Am Chem Soc 2001; 123: 10799-10804.
36. Bryan MT, Jarstfer MB. Interrogation of G-quadruplex-protein interactions. Methods 2007; 43: 332-339.
37. Nagatoishi S, Nojima T, Juskowiak B, Takenaka S. A pyrene-labeled G-quadruplex oligonucleotide as a fluorescent probe for potassium ion detection in biological applications. Angew Chem Int Ed Engl 2005; 44: 5067-5070.
38. Treuheit NA, Beach MA, Komives EA. Thermodynamic compensation upon binding to exosite 1 and the active site of thrombin. Biochemistry 2010; 50: 4590-4596.
39. Colwell NS, Blinder MA, Tsiang M, Gibbs CS, Bock PE, Tollefsen DM. Allosteric effects of a monoclonal antibody against thrombin exosite II. Biochemistry 1998; 37: 15057-15065.